clinical infectious diseases

期刊名称 clinical infectious diseases 

期刊缩写 CLIN INFECT DIS    
学科分类 医学、生命科学 

出版周期 半月刊   
审稿速度 4-6周 

投稿命中率 50 % （均值)   
期刊主页 http://cid.oxfordjournals.org/   
ISSN 号 (printed): 1058-4838 (electronic): 1537-6591   
IF 趋势   2005     2006     2007     2008      2009     2010      2011       2012    
              6.51      6.186     6.75     8.266     8.195     8.186     9.154      9.374   
被收录情况   1. Science Citation Index 
                    2. Science Citation Index Expanded 
                    3. Current Contents - Clinical Medicine 
                    4. Current Contents - Life Sciences 
                    5. BIOSIS Previews   
PubSci评语 美国传染病学会的官方期刊，在传染病领域具有相当高的认可度。审稿周期在4-6周，会给出详细的修改意见，不接受一稿多投。耐药及MRSA这类文章较好发表。   
期刊简介 CID是美国传染病学会的官方期刊，是传染病领域具有广泛读者群的高水准杂志。该刊收录的范围包括传染病的临床描述、公共卫生、微生物学、预防感染的免疫原、目前以及新疗法的评估以及诊断和治疗的最优实践的提升等。   
投稿注意事项 特别提醒：前6页，每页收费55美元，其后每页85美元。邀请的文章、通讯稿以及仅在线发表的文章不收此项费用。印刷方式发表的彩页收费，首页500美元/265英镑/395欧元，其后每页400美元/210英镑/315欧元，黑白颜色不收费。选择Open Access方式发表论文的作者缴费标准如下：对于CC-BY类型的作者，一般缴费2188英镑/3500美元/2844欧元，B类发展中国家的作者为1094英镑/1750美元/1422欧元，A类发展中国家的作者免费。对于CC-BY-NC-ND 类型的作者，一般缴费1875英镑/3000美元/2438欧元，B类发展中国家的作者为937.5英镑/1500美元/1219欧元，A类发展中国家的作者免费。
一般注意事项：

manuscript preparation instructions
Submission
How to contact the Editorial Office
Language editing pre-submission
Article Types
Manuscript format and structure
Technical Details
Journal copyediting style
Figures and illustrations
Permission to reproduce figures and extracts
Supplementary data
Copyright and license
Proofs
Offprints
Advance Access

Please note that the journal now encourages authors to complete their copyright licence to publish form online.
SUBMISSION
Please read these instructions carefully and follow them closely to ensure that the review and publication of your paper is as efficient and quick as possible. The Editors reserve the right to return manuscripts that are not in accordance with these instructions.
All material to be considered for publication in Clinical Infectious Diseases should be submitted in electronic form via the journal's online submission system at http://www.editorialmanager.com/cid/. Once you have prepared your manuscript according to the instructions below, instructions on how to submit your manuscript online can be found by clicking here.
Supporting Documents
All submitted manuscripts should include the following supporting documents:
Cover Letter
The cover letter must include the completed contact information [addresses, telephone and fax numbers, and e-mail] for both the corresponding author and an alternate author who can be contacted if the corresponding author is unavailable. The letter should warrant that all authors have seen and approved the manuscript, contributed significantly to the work, and also that the manuscript has not been previously published nor is not being considered for publication elsewhere. Authors are asked to provide names and contact information for 4 potential unbiased reviewers. They may also note the names of individuals whom they do not want to review their manuscript. Authors also should state in their cover letter whether they would bear the cost of reproducing their color figures or whether they prefer to have them published in black and white at no additional cost.
Related Manuscripts
A copy should be included of any closely related manuscript submitted to or published in CID or elsewhere, as noted in the journal’s Duplicate Publication Policy.
Permissions
In order to reproduce any third party material, including figures or tables, in an article authors must obtain permission from the copyright holder and be compliant with any requirements the copyright holder may have pertaining to this reuse. 

When seeking to reproduce any kind of third party material authors should request the following: 

(i) non-exclusive rights to reproduce the material in the specified article and journal; 
(ii) electronic rights, preferably for use in any form or medium; 
(iii) the right to use the material for the life of the work; and 
(iv) world-wide English-language rights. 

Further guidelines on clearing permissions can be found at:http://www.oxfordjournals.org/access_purchase/permissions_guidelines.doc. 

Authors should also include a statement indicating that permission has been obtained in the relevant legend/footnote and provide the Editorial Office with copies of any relevant paperwork. 

A template permissions request letter can be found at the end of the above document.
Submitting Articles to PubMed Central or PubMed Central UK
Authors whose research was funded in whole or in part by the National Institutes of Health (NIH), the Wellcome Trust, the Howard Hughes Foundation (HHF), Medecins Sans Frontieres (MSF), or the Medical Research Council (MRC UK) may deposit the accepted manuscript with PubMed Central or PubMed Central UK, with release to the public twelve (12) months after publication for NIH-funded research or six (6) months after publication for Wellcome Trust-funded and Medical Research Council-funded research and immediate release for HHF and MSF articles. Only the final accepted manuscript may be submitted; authors may not submit proofs or the published article to PubMed Central or PubMed Central UK.
Return to top of page.
HOW TO CONTACT THE EDITORIAL OFFICE
The Editorial Office can be contacted as follows:
Clinical Infectious Diseases 
Tufts University School of Medicine 
200 Harrison Avenue 
Posner Basement 
Boston, Massachusetts 02111 
Telephone: (617) 636-2780; Fax: (617) 636-4060 
E-mail: cid@tufts.edu
Return to top of page.
LANGUAGE EDITING PRE-SUBMISSION
Language editing, if your first language is not English, to ensure that the academic content of your paper is fully understood by journal editors and reviewers is optional. Language editing does not guarantee that your manuscript will be accepted for publication. For further information on this service, please click here. Several specialist language editing companies offer similar services and you can also use any of these. Authors are liable for all costs associated with such services.
Return to top of page.
ARTICLE TYPES
Papers may be submitted in the following categories. The editors reserve the right to change the category for consistency with CID style.
Major Articles
Report clinically relevant investigations or observations within CIDs scope of interests. 

Format guide: 
• Word limit: 3000 words (excluding the abstract and references). 
• Key points should be summarized on the title page in 40-words or less. 
• References: 40 or less. 
• Abstract: Up to 250 words, structured using the headings Background, Methods, Results and Conclusions. 
• Tables/Figures: Data in the text should not be repeated extensively in tables or figures.
Brief Reports
Convey a focused message. Case reports are considered Brief Reports and have the same length requirements. Case reports should present unusual aspects of common problems or novel perspectives upon, or solutions to, clinically relevant issues. 

Format guide: 
• Word limit: 1500 words (excluding the abstract and references). 
• References: 10-12. 
• Abstract: Up to 50 words, unstructured format 
• Tables/Figures: 1 table or figure.
Review Articles
Review topics should be related to clinical aspects of infectious diseases and should reflect trends and progress or a synthesis of data. 

Format guide: 
• Word limit: 3000 words (excluding the abstract and references). 
• Key points should be summarized on the title page in 40-words or less. 
• References: 40 or less. 
• Abstract: Up to 150 words, unstructured. 
•Tables/Figures: Data in the text should not be repeated extensively in tables or figures.
Viewpoints
We welcome viewpoints that present the opinions of the authors rather than new experimental data or literature reviews. 

Format guide: 
• Word limit: 3000 words (excluding the abstract and references). 
• Key points should be summarized on the title page in 40-words or less. 
• References: 40 or less. 
• Abstract: Up to 150 words, unstructured. 
• Tables/Figures: Data in the text should not be repeated extensively in tables or figures.
Editorials
Editorials relate to articles published in CID and are invited at the discretion of the Editor. 

Although most editorials are commissioned, CID will consider unsolicited Editorials. Please write a brief summary of your proposed editorial and email it to the editorial office. 

Format guide: 
• Word limit: 1200 words. 
• Tables/Figures: A maximum of 1 figure or table. 
• References: 10 or less. 
• Ensure that there is a clear message in the conclusion.
Special Sections
Special Sections address areas of particular interest to CID and primarily contain articles solicited by the Special Section Editors from experts in each area. 

Format guide: 
• Word limit: 3000 words (excluding the abstract and references). 
• Key points should be summarized on the title page in 40-words or less. 
• References: 40 or less. 
• Abstract: Up to 150 words, unstructured. 
• Tables/Figures: Data in the text should not be repeated extensively in tables or figures.
Photo Quizzes
Photo Quizzes are question-and-answer challenges that illustrate an unusual illness and that invite a diagnosis from the reader. The question portion may state the history of the case and note the findings and the outcome, but it should not divulge the diagnosis. 

Format guide: 
• Question should be written in a single paragraph. 
• Figures: 3 or less. 
• Answer should give the diagnosis and outline or include the key teaching points. 
• Separate figure legends for the question and answer must be included with the submission with arrows marking their key elements.
Correspondence
Letters to the Editor should respond to a recently published article in CID or address an issue of interest to CID readers. Replies will be published in the same issue as the letter, and are invited at the discretion of the Editor. 

Format guide: 
• Word limit: 500 words. 
• Tables/Figures: A maximum of 1 figure or table 
• References: 10 or less. 
• No subheadings. 
• Begin with ‘Dear Editor’
Supplements
Supplements may be the proceedings of a symposium or the results of a study and are sponsored by universities, organizations, drug companies, and grants. Proposals related to suitability of topic, program organization, and production must be made in writing to the Editor. 

Proposal format guide: 
1.List of all topics to be covered 
2.Estimated length of supplement 
3.The complete contact information for a Guest Editor(s) 
4.Potential authors and affiliations 
5.The name and contact information for the sponsoring organization
Return to top of page.
MANUSCRIPT FORMAT AND STRUCTURE
Please refer to a recent issue of Clinical Infectious Diseases for guidance on style and layout of articles. Also refer to the Article type section for guidance on relevant information for each article type.
File Formats
The preferred format for submitting manuscripts online is Microsoft Word (.doc files). PDF files are not acceptable for submission.
File Contents
Manuscript .doc submissions are preferred as a single file, except for figures, which can be uploaded separately. You must also submit a cover letter in a second file, in the same format as your main file. Videos must be submitted in the MPEG or Quicktime format. For each video, please submit a still image captured from the MPEG or Quicktime file; this image will appear as a printable figure with the article. A video must have a legend that will appear with the still image. If you wish to submit a video, please consult with the CID editorial office for further details.
Manuscript Preparation
Manuscripts should be double-spaced throughout, including the references and the table and figure legends, with 1-inch margins on each side. All pages, except for the figures, should be numbered in the lower right-hand corner of the page, with the title page as page 1. The recommended layout is as follows: title page, abstract, text, acknowledgments, references, tables, figure legends, and figures.
Title Page
All manuscripts, including Correspondence, should have a title page that includes the following information: 

1. A concise, informative title 
2. The names and affiliations of all authors. The first name, initial(s), and surname of each author should be followed by his or her department, institution, city, and country. 
3. Up to 5 keywords 
4. A running title of no more than 40 characters and spaces 
5. The complete contact information for both the corresponding and alternate corresponding authors. 
6. Major Articles, Reviews, and Viewpoints should also include a 40-word summary of the article’s main point. 

It is editorial policy to list only one author for correspondence. We do not accept co-first authors, nor co-corresponding authors. However, it is acceptable to state that “author X, author Y, etc. contributed equally to this manuscript.” 

Any changes of address may be given next to the Affiliations or in the Acknowledgments. Any deletions or additions to the author list after submission of the paper must be submitted in writing, and signed by all authors.
Abstract
The second page of the manuscript should contain the Abstract. Please refer to the Article Type for Abstract formats. The Abstract should be comprehensible to readers before they have read the paper and should not contain reference citations.
Abbreviations
Non-standard abbreviations should be kept to a minimum. They should be defined at the first occurrence and introduced only where multiple use is made.
Text
Authors are encouraged to follow the Uniform Requirements for Manuscripts Submitted to Biomedical Journals. They should strive for a concise article without excessive detail (word limits are specified under Categories of Articles. All but the shortest articles should have subheadings.
Funding
Details of all funding sources for the work in question should be given in a separate section entitled “Funding.” This should appear before the “Acknowledgment” section. 

The following rules should be followed: 

• The sentence should begin: “This work was supported by …” 
• The full official funding agency name should be given, ie “the National Cancer Institute at the National Institutes of Health” or simply “National Institutes of Health” not “NCI” (one of the 27 subinstitutions) or “NCI at NIH.” Please see here for a full RIN-approved list of UK funding agencies. 
• Grant numbers should be complete and accurate and provided in brackets as follows: “[grant number ABX CDXXXXXX]” 
• Multiple grant numbers should be separated by a comma as follows: “[grant numbers ABX CDXXXXXX, EFX GHXXXXXX]” 
• Agencies should be separated by a semi-colon (plus “and” before the last funding agency) 
• Where individuals need to be specified for certain sources of funding the following text should be added after the relevant agency or grant number “to [author initials].” 

An example is given here: “This work was supported by the National Institutes of Health [P50 CA098252 and CA118790 to R.B.S.R.] and the Alcohol & Education Research Council [HFY GR667789].”
Conflict of Interest
Further guidance on Conflict of Interests is available here.
Acknowledgments
Personal acknowledgment should precede those of institutions of agencies. Any substantial assistance in preparing the manuscript—for example, in data retrieval or statistical analysis—other than by an author should be stated. 

Please note that acknowledgment of funding bodies and declarations regarding conflicts of interest should be given in separate Funding and Conflicts of Interest sections, respectively. 

Further guidance on Conflict of Interests is available here.
References
EndNote and Reference Manager are software programs for publishing and managing references/bibliographies, which are available from Thomson Reuters. If you use EndNote or Reference Manager to facilitate referencing citations, this journal’s style is available for use. The EndNote program and relevant information can be found here: http://www.endnote.com/support/enstyles.asp. Please follow the instructions on this page regarding purchasing, downloading, and using the software. 

CID reference style is based on the Uniform Requirements for Manuscripts Submitted to Biomedical Journals.
Names of journals are abbreviated according to the List of Journals Indexed for Medline. Titles of journals not listed in Medline should be spelled out in full. References should be numbered consecutively as they appear in the text, with the numbers in brackets on the text line (e.g., [3, 7–9, 57]). References first cited in tables or figures should be in sequence with those in the text; for example, if table 1 is mentioned in the text after reference [8], the next new reference cited in table 1 will be reference [9]. Unpublished data should be cited in the text as (unpublished data), but not included in the references list. References to manuscripts submitted, but not yet accepted, should be cited in the txt as (B Jones and L Smith, manuscript in preparation) and should not be included in the reference list. Citations of submitted manuscripts should include all authors involved. For references with >6 authors, the first 3 authors should be listed, followed by et al. Reference to a doctoral dissertation should include the author, title, institution, location, year, and publication information, if published. For online resources, a URL and date accessed should be included. Accuracy of references is the responsibility of the authors. 

The citation of journals, books, multi-author books, and articles published online should conform to the following examples:
Gorecki DC, Monaco AP, Derry JMJ, Walker AP, Barnard, EA, Barnard, PJ. Expression of four alternative dystrophin transcripts in brain regions regulated by different promoters. Hum Mol Genet,1995; 155: 505-511.
Francis V, Bastin M. (2000) Gene targeting in rat embryo fibroblasts promoted by the polyomavirus large T antigen. Nucleic Acids Res [in press].
Maniatis T, Fritsch EF, Sambrook J. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1982.
Huynh TV, Young RA, Davis RW. DNA Cloning. In: Glover DM. DNA Cloning - A Practical Approach. Vol 1. Oxford, UK: IRL Press; 1988:49-78.
Public Health Service Task Force. Recommendations for the use of antiretroviral drugs in pregnant HIV-1 infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States. Available at: http://www.aidsinfo.nih.org. Accessed 24 April 2002.
Lyon DJ, Cheng AFB, Norrby SR. Mechanisms of cefotaxime resistance in blood culture isolates of Enterobacter high prevalence of extended-spectrum β-lactamases [abstract C43]. In: Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy (San Francisco). Washington, DC: American Society for Microbiology, 1995:47.
Tables
All tables should be on separate pages and accompanied by a title, and footnotes where necessary. The tables should be numbered consecutively using Arabic numerals. Units in which results are expressed should be given in parentheses at the top of each column and not repeated in each line of the table. Ditto signs are not used. Avoid overcrowding the tables and excessive words. The format of tables should be in keeping with that normally used by the journal; in particular, vertical lines, colored texts, and shading should not be used. Please be certain that the data given in tables are correct. 

In a footnote to the table, all abbreviations used should be defined, unless otherwise defined in the text, excluding units of measure. Footnotes and accompanying explanatory material should be kept to a minimum. Footnotes should be placed below the table and designated by superscript lowercase letters (listed in order of location when the table is read horizontally). Each column must have a heading describing the data below, and units of measure must be clearly indicated for all data. 

For further details on table formatting, please click here.
Figure Legends
Figure legends 
These should be on a separate, numbered manuscript sheet. Define all symbols and abbreviations used in the figure. Figures and legends should be intelligible without reading the text of the manuscript.
Return to top of page.
MANUSCRIPT DETAILS
Nomenclature
CID attempts to use the latest widely accepted nomenclature. See Bergey's Manual of Determinative Bacteriology (9th ed., revised, Williams & Wilkins, 1994) and Enzyme Nomenclature: Recommendations of the Nomenclature Committee of the International Union of Biochemistry and Molecular Biology on the Nomenclature and Classification of Enzymes (Academic Press, 1992). Formal terms for virus families, genera, and species should be those approved by the International Committee on Taxonomy of Viruses; see Virus Taxonomy—The Classification and Nomenclature of Viruses: Seventh Report of the International Committee on Taxonomy of Viruses (Academic Press, 2000). This volume also includes standard abbreviations for virus species. For names and abbreviations of chemical compounds, refer to the Merck Index (13th ed., Merck, 2001). The Editors appreciate the assistance of authors and readers who inform them of changes in nomenclature.
Human Genetic Nomenclature and Notation
For human genes, use genetic notation and symbols approved by the Human Gene Mapping Workshop (see Wain HM, Bruford EA, Lovering RC, Lush MJ, Wright MW, Povey S. Guidelines for human gene nomenclature. Genomics 2002; 79:464–70). Human gene names and loci should be written in italicized capital letters and Arabic numerals. Human protein product names are not italicized. For human mutation nomenclature, see Antonarakis et al. (Recommendations for a nomenclature system for human gene mutations. Hum Mutat 1998; 11:1–3).
Human Single-Nucleotide Polymorphisms (SNPs)
For human genes, newly described SNPs should be submitted to an appropriate database, such as dbSNP (http://www.ncbi.nlm.nih.gov/SNP/), prior to submission of the revised manuscript. The identification numbers of previously recognized SNPs (rs numbers) or recently submitted SNPs (ss numbers) should be provided in the manuscript, if the number of SNPs is small, or submitted as supplemental online material, if the number is large.
Statistical analysis
The statistical analyses used should be identified both in the text and in all tables and figures where the results of statistical comparison are shown.
Units of measurement
The use of SI units is encouraged. All data should be expressed in metric units. Temperature should be expressed in degrees Celsius.
Return to top of page.
JOURNAL COPYEDITING STYLE
Authors are referred to the AMA Manual of Style: A Guide for Authors and Editors (10th ed., Oxford University Press, 2007) and the Chicago Manual of Style (16th ed., University of Chicago Press, 2010). For commercially obtained products mentioned in the text, the full names of manufacturers should be listed. Generic names of drugs and other chemical compounds should be used.
Return to top of page.
FIGURES AND ILLUSTRATIONS
Patient’s identity must be removed in all figures (i.e., x-rays, MRIs, charts, photographs, etc.). Written informed consent is required from any potentially identifiable patient or legal representative, and should be presented in either the Methods section or the Acknowledgements. 

Figures should also be numbered in the order of mention in the text and should appear at the end of the manuscript and references. Figures will not be relettered by the publisher. The journal reserves the right to reduce the size of illustrative material.
Formatting
Multipart figures should be submitted as a single file, with panels labeled within the image, rather than as multiple files. Letters, numbers, and symbols should be clear and of sufficient size to be legible when the figures are reduced. Photomicrographs should have internal scale markers. If the manuscript is accepted, the author will be required to supply high resolution figure files for production. 

Save figure files in TIFF or EPS format, using CMYK colors, with fonts embedded. When creating figures, please make sure any embedded text is large enough to read. If figures contain miniscule characters such as numbers on a chart or graph, they will most likely be illegible in the final version. 

For useful information on preparing your figures for publication, go to http://cpc.cadmus.com/da.
Halftone illustrations, photographs
Any photomicrogaphs, electron micrographs, or radiographs must be of high quality with respect to detail, contrast, and fineness of grain to withstand the inevitable loss of contrast and detail inherent in the printing process . Wherever possible, photographs should fit within the print area or within a column width. Photomicrographs should provide details of staining technique and a scale bar. Patients shown in photographs should have their identity concealed or should have given their written consent to publication. Please indicate the magnification by a bar on the photograph. Minimum resolutions are 300 d.p.i for color or tone images.
Line Drawings
All line drawings should have clear and sharp lines. No additional artwork, redrawing, or typesetting will be done. Therefore, all labeling should be done on the original line drawing. Faint shading and stippling could be lost upon reproduction and should be avoided. Line drawings must have a resolution of at least 600 d.p.i. at their final size.
Color Illustrations
Authors are required to pay the full cost of reproduction of color figures. For details see Clinical Infectious Diseases charges. If you require color reproduction of figures in the print journal you will be asked to approve the cost. An invoice will be issued at the time of publication. 

Clinical Infectious Diseases also offers free reproduction of color figures in the online version (figures in the print version will appear in black and white). Figure captions must be suitable worded to apply to both the print and online versions of the article.
Return to top of page.
PERMISSION TO REPRODUCE FIGURES AND EXTRACTS
For a copyright prose work, it is recommended that permission is obtained for the use of extracts longer than 400 words; a series of extracting totally more than 800 words, or which any one extract is more than 300 words; or an extract or series of extract compromising one-quarter of the work or more.
Permission to reproduce copyright material, for print and online publication in perpetuity, must be cleared and if necessary paid for by the author; this includes applications and payments to DACS, ARS, and similar licensing agencies where appropriate. Evidence in writing that such permissions have been secured from the rights-holder must be made available to the editors. It is also the author's responsibility to include acknowledgements as stipulated by the particular institutions. Oxford Journals can offer information and documentation to assist authors in securing print and online permissions: please see the Guidelines for Authors section.
Return to top of page.
SUPPLEMENTARY DATA
Supplementary data is supporting material that cannot be included in the printed version for reasons of space and is not essential for inclusion in the full text of the manuscript but would nevertheless benefit the reader. The material should not be essential to understanding the conclusions of the paper but should contain data that is additional or complementary and directly relevant to the article content. Such information might include more detailed methods, extended data sets/data analysis, or addition figures or tables. 
It is standard practice for appendices to be made available online-only as supplementary material. All text and figures must be provided in suitable electronic formats. All material to be considered as supplementary material must be submitted at the same time as the main manuscript for peer review. It cannot be altered or replaced after the paper has been accepted for publication, and will not be edited. Files for supplementary data should be clearly marked as such and be accompanied by a summary of the file names and types. Also ensure that the supplementary material is referred to in the main manuscript where necessary, for example as "(see Supplementary Material)" or "(see Supplementary Figure 1)." 

Please note that supplementary data will not be copyedited, so ensure that it is clearly and succinctly presented, and that the style of terms conforms with the rest of the paper. It cannot be altered or replaced after the paper has been accepted for publication.
Return to top of page.
COPYRIGHT AND LICENSE
It is a condition of publication in Clinical Infectious Diseases that the authors grant an exclusive license to the journal’s sponsoring society, the Infectious Diseases Society of America. This ensures that all of the necessary rights needed for publication of the article are in place including provision for any requests from third parties to reproduce the content to be as widely disseminated as possible. No article will be published unless the signed license has been received at Oxford Journals. On acceptance of your article for publication, the license form should be returned immediately by fax or by sending a scanned PDF copy, and the original must be posted as soon as possible. Faxing a copy of the form when requested will assist in the rapid publication of your article but the Original form should also be returned. Any queries about the license form should be sent as soon as possible to Rights and permissions so that any issues can be resolved quickly and to avoid any delay in publication.
As part of the license agreement, authors may use their own material in other publications, provided that the journal is acknowledged as the original place of publication and Oxford University Press is acknowledged as the publisher. 

Upon receipt of accepted manuscripts at Oxford Journals authors will be invited to complete an online copyright license to publish form.
Work submitted for publication must be original, previously unpublished, and not under consideration for publication elsewhere. If previously published figures, tables, or parts of text are to be included, the copyright-holder’s permission must have been obtained prior to submission. For more information on how to obtain permissions, please consult Rights and Permissions.
Return to top of page.
PROOFS
Authors are sent page proofs by email. To avoid delays in publication, proofs should be checked immediately and corrections, as well as answers to any queries, returned to the publishers as an annotated PDF via email or fax within 2 working days. Further details are supplied with the proof. It is the author’s responsibility to check proofs thoroughly. 

Excessive alterations in the proof stage may delay publication of the article to a subsequent issue. Authors who make extensive amendments to the text at the page-proof stage will be charged an additional fee.
Return to top of page.
OFFPRINTS
The journal will provide a URL to authors for free electronic access to the published version of the article. The corresponding author is entitled to receive 25 printed offprints free of charge. These can be claimed using the Oxford Journals Author Services site. Reprints may be purchased in multiples of 50.
Return to top of page.
ADVANCE ACCESS
Advance Access allows for papers to be published online soon after they have been accepted for publication—reducing the time between submission and publication. Articles posted for Advance Access have been copyedited and typeset but have not yet paginated for inclusion in a specific issue of the journal. Appearance in Advance Access constitutes official publication, with full-text functionality, and the Advance Access version can be cited by a unique DOI (Digital Object Identifier). The final manuscript is then paginated into an issue, at which point it is removed from the Advance Access page. Both versions of the paper continue to be accessible and citable.
Model B: Articles posted for Advance Access have been copyedited and typeset and any corrections included. This is before they are paginated for inclusion in a specific issue of the journal. Once an article appears in an issue, both versions of the paper continue to be accessible and citable.   
编辑部信息 所在地：  国家 美国   
  Editorial Board
EDITOR-IN-CHIEF
Sherwood L. Gorbach
DEPUTY EDITOR
Michael Barza
ASSISTANT DEPUTY EDITOR
Sara E. Cosgrove
ASSOCIATE EDITORS
Barbara D. Alexander
Neil R. Blacklow
Donald A. Goldmann
Camilla S. Graham
John R. Graybill
Adolf W. Karchmer
Jerome O. Klein
Robert T. Schooley
Cynthia L. Sears
Lucy S. Tompkins
Christine Wanke
COVER ART EDITORS
Mary Grizzard
Michael Grizzard
STATISTICAL EDITORS
Steven A. Cohen
Norma Terrin
Farzad Noubary
HISTOPATHOLOGY EDITORS
Ann Marie Nelson
Mary Klassen-Fischer
EDITORIAL OFFICE STAFF
Carlos M. Terra, Managing Editor
Claire R. Neumann, Acquisitions Editor
Diana Cerrone, Manuscript Coordinator
Emily Wheeler, Editorial Office Assistant 

网友投稿经验整理：
杂志名称：Clinical Infectious Diseases 

专业领域：感染 
杂志国家：美国 
投稿年份：2009.2 
审稿周期: 4-6周 
是否经历大小修：被拒 
从开始投稿到接受（拒稿）多长时间：投稿到被拒1月 
期间是否要求润色语言：否 
是否收版面费：否，额外彩图需要 
个人评述（感受或经验）：送审比较快，会给出比较详细的修改意见，但是不要一稿多投，有朋友的很好的文章因此被毙
贡献者： medison
杂志名称：Clinical Infectious Diseases 

专业领域：感染 
杂志国家：美国 
投稿年份：2009.12 
审稿周期: 4周 
是否经历大小修：被拒